Retatrutide
Reta · LY3437943 · GIP/GLP-1/glucagon triple agonist
Synthetic single-chain peptide studied as an agonist at the GIP, GLP-1 and glucagon receptors.
$89.99
Usually delivered in 2–5 business days · Ships from US stock
Store opening soon. Prices are shown for reference; ordering opens at launch.
- Batch report
- Lookup by lot
For in-vitro laboratory research only. Not for human or veterinary use.
Description
Retatrutide (LY3437943) is a synthetic, lipidated single-chain peptide studied in vitro as an agonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon receptors. It is an investigational substance and is not an approved drug. PubChem does not list this name against a compound record, so no identifiers are published on this page; lot-specific values appear on each certificate of analysis.
Intended use
For in-vitro laboratory research and analytical use by qualified institutions. Not for human or veterinary use, and not for use in food, drugs, cosmetics or household products.
Specifications
No identifiers have been confirmed against a cited source yet.
Batch reports (COA)
No independently verified batch report yet.
The manufacturer's report below is published exactly as we received it and has not been confirmed with the laboratory. Check that its lot number matches the one on your vial.
- Manufacturer's report · retatrutide 10 mg · lot RT10-20260923S5031 · analysed 23 Sep 2026As received from the supplier · not independently verifiedDownload
Storage & Handling
Storage and handling details come from the supplier specification and Safety Data Sheet, and are published here once both are on file.
References
Questions about Retatrutide?
Ask us